Cellecta focuses on developing and implementing flexible and scalable broad-based approaches for screening and analysis to expedite the discovery and characterization of novel therapeutic targets and drugs. Strongly research oriented, we have amassed experience and technical expertise with CRISPR, RNAi, lentiviral vector systems, mammalian cell culture, next generation sequencing (NGS), RT-PCR and gene expression analysis.
To enable investigators to leverage our knowledge, proficiency, and capabilities to advance their research programs, we offer a range of services, including genome-wide functional genetic screens using pooled RNAi and CRISPR libraries, transriptome profiling, cell engineering, and targeted knockdown and knockout constructs.
- CRISPR and RNAi Genetic Screening Services
- Custom Pooled Lentiviral Libraries
- Engineered Custom Cell Lines
- Driver-MapTM Expression Profiling Service
- Individual Lentiviral Custom Constructs
- Lentiviral Packaging Services
- Next-Generation Sequencing of Samples from High-Throughput Genetic Screens
In addition to our defined offering, we, as a small flexible research-focused group, are always interested in hearing about new opportunities and projects. Many potential projects do not fit into a simple defined service, and we are always interested to bring our experience and knowledge to bear on new and challenging research. If you think we might be able to help you with a difficult research problem or complex project, please contact us to discuss your idea. Much of our technology development begins as collaborations to solve practical research challenges.
And don’t forget to check out our offering of off-the-shelf, ready-to-use products which could simplify your experiments and save you valuable time.
If you wish to receive the latest news and product updates by email, please register now.